| Aktie | Ticker | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | ||||
|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ Veränd. ($) | Investment ($) | QoQ Veränd. ($) | Investment ($) | QoQ Veränd. ($) | Investment ($) | QoQ Veränd. ($) | ||
| 823.679.402 $ | +164.306.720 $ | 659.757.896 $ | +233.148.367 $ | 455.625.029 $ | -50.064.813 $ | 516.795.482 $ | +516.795.482 $ | ||
| BANK OF AMERICA CORP /DE/ | BAC | 796.943.043 $ | +157.697.861 $ | 639.245.182 $ | +226.470.371 $ | 412.774.811 $ | +9.423.437 $ | 403.351.374 $ | +403.351.374 $ |
| BARCLAYS PLC | BCS | 385.214 $ | +84.696 $ | 300.518 $ | -47.801.690 $ | 48.102.208 $ | +48.102.208 $ | ||
| Centessa Pharmaceuticals plc | CNTA | 18.757.500 $ | -1.370.000 $ | 20.127.500 $ | +6.593.300 $ | 13.534.200 $ | -15.585.300 $ | 29.119.500 $ | +29.119.500 $ |
| aTYR PHARMA INC | ATYR | 19.367.400 $ | +8.640.360 $ | 10.727.040 $ | +10.727.040 $ | ||||
| MoonLake Immunotherapeutics | MLTX | 6.985.600 $ | -4.579.120 $ | 11.564.720 $ | +11.564.720 $ | ||||
| Syndax Pharmaceuticals Inc | SNDX | 11.105.640 $ | +11.105.640 $ | ||||||
| PRECISION BIOSCIENCES INC | DTIL | 7.978.859 $ | +7.978.859 $ | ||||||
| JPMORGAN CHASE & CO | JPM | 2.662.500 $ | -162.500 $ | 2.825.000 $ | +2.825.000 $ | ||||
| 823.679.402 $ | +164.306.720 $ | 659.757.896 $ | +233.148.367 $ | 455.625.029 $ | -50.064.813 $ | 516.795.482 $ | +516.795.482 $ | ||
Erweiterte Einstellungen
×